
Alexandra Drakaki, MD, on managing peripheral neuropathy on enfortumab vedotin
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQdHF2RGxzenJWM1JoQ1hCcWlhaVlKSjhHalBRSWR0UFBla1p5dzM2S3VCRVJoZHlkTzN4UTJ1SWdEdHZiZ1RjNTJSVEFlUUc3NDI3eFExS0RfQ3RRSmhiM3d1V2hDanZkRmVkWDNsUGxqeW1pYlNuMF8tblVTZFVtRGZSRnBKT0RIYkZWVVQ5THd1LV9JbHBZb1dKczFSeXRjdnE4VEtGYVVxcWkxdmE0?oc=5" target="_blank">Alexandra Drakaki, MD, on managing peripheral neuropathy on enfortumab vedotin</a>&nbsp;&nbsp;<font color="#6f6f6f">Urology Times</font>
